ClinVar Genomic variation as it relates to human health
NM_001377265.1(MAPT):c.2185G>A (p.Val729Met)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001377265.1(MAPT):c.2185G>A (p.Val729Met)
Variation ID: 14252 Accession: VCV000014252.9
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17q21.31 17: 46018629 (GRCh38) [ NCBI UCSC ] 17: 44095995 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2014 Feb 14, 2024 Nov 18, 2020 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001377265.1:c.2185G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001364194.1:p.Val729Met missense NM_001123066.4:c.2014G>A NP_001116538.2:p.Val672Met missense NM_001123067.4:c.922G>A NP_001116539.1:p.Val308Met missense NM_001203251.2:c.829G>A NP_001190180.1:p.Val277Met missense NM_001203252.2:c.916G>A NP_001190181.1:p.Val306Met missense NM_001377266.1:c.1894G>A NP_001364195.1:p.Val632Met missense NM_001377267.1:c.771+4351G>A intron variant NM_001377268.1:c.742G>A NP_001364197.1:p.Val248Met missense NM_005910.6:c.1009G>A NP_005901.2:p.Val337Met missense NM_016834.5:c.835G>A NP_058518.1:p.Val279Met missense NM_016835.5:c.1960G>A NP_058519.3:p.Val654Met missense NM_016841.5:c.742G>A NP_058525.1:p.Val248Met missense NR_165166.1:n.840G>A non-coding transcript variant NC_000017.11:g.46018629G>A NC_000017.10:g.44095995G>A NG_007398.2:g.129167G>A LRG_660:g.129167G>A LRG_660t1:c.1960G>A LRG_660p1:p.Val654Met LRG_660t2:c.2185G>A LRG_660p2:p.Val729Met P10636:p.Val654Met - Protein change
- V337M, V654M, V306M, V308M, V279M, V248M, V277M, V672M, V632M, V729M
- Other names
- -
- Canonical SPDI
- NC_000017.11:46018628:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MAPT | No evidence available | No evidence available |
GRCh38 GRCh38 GRCh38 GRCh37 |
509 | 643 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, single submitter
|
Nov 18, 2020 | RCV000015321.35 | |
not provided (1) |
no classification provided
|
- | RCV000084548.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Nov 18, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Frontotemporal dementia
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001201306.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 14, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect MAPT protein function (PMID: 20377816, 11756496). This variant … (more)
For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect MAPT protein function (PMID: 20377816, 11756496). This variant has been observed in individual(s) with frontotemporal dementia (PMID: 9629852, 28130473). It has also been observed to segregate with disease in related individuals. This variant is also known as Val279Met in the literature. ClinVar contains an entry for this variant (Variation ID: 14252). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with methionine at codon 337 of the MAPT protein (p.Val337Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. (less)
|
|
Pathogenic
(Mar 01, 2001)
|
no assertion criteria provided
Method: literature only
|
DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000035580.3
First in ClinVar: Apr 04, 2013 Last updated: May 10, 2021 |
Comment on evidence:
Poorkaj et al. (1998) identified 9 DNA sequence variants in 2 families with what they referred to as FTDP17 (600274); 8 of these were also … (more)
Poorkaj et al. (1998) identified 9 DNA sequence variants in 2 families with what they referred to as FTDP17 (600274); 8 of these were also identified in controls and were thus considered polymorphisms. The ninth variant, VAL279MET, was found in 1 FTDP17 family, but not in the other. (This mutation is designated val337 to met in the numbering used by Hutton et al. (1998); see 157140.0001.) The change was considered positive since it occurred in a highly conserved residue and a normal valine is found at this position in all 3 tau interrepeat sequences and in other MAPT homologs. Furthermore, the mutation cosegregated with the disease in the family and was not found in normal controls. At the time that the paper of Poorkaj et al. (1998) was submitted, the longest amino acid form of tau in the database did not include all of the alternatively spliced exons (Poorkaj, 1998). Using purified recombinant proteins, Alonso et al. (2004) showed that several FTDP17-associated tau mutations, including V337M, made tau a more favorable substrate for abnormal hyperphosphorylation compared with wildtype tau. Both the phosphorylation kinetics, due to induced conformational changes, and the phosphorylation stoichiometry, due to increased phosphorylation of more than a single site, were more favorable in the mutant proteins. The mutant proteins polymerized into filaments more readily than wildtype tau, leading to decreased ability to bind wildtype tau. Sohn et al. (2019) found that the FTD-associated tau V337M mutant shortened the axon initial segment (AIS) and impaired AIS plasticity in human induced pluripotent stem cell (iPSC)-derived neurons. Electrophysiologic properties of tau V337M neurons revealed that the mutation also impaired homeostatic control of spontaneous neuronal activity in response to depolarization. End-binding protein-3 (EB3, or MAPRE3; 605788), a component of the AIS cytoskeleton, was associated with ANKG (106280) and tau in the AIS submembrane region of human neurons. However, the V337M mutation increased the binding affinity of tau with EB3, leading to increased EB3 accumulation in the AIS in tau V337M mutant neurons. EB3 accumulation increased its interaction with ANKG and promoted its structural stability via physical interaction with microtubules, thereby impairing AIS plasticity in tau V337M mutant neurons. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
VIB Department of Molecular Genetics, University of Antwerp
Accession: SCV000116684.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014
Comment:
http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg18&id=ADM_189
|
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis. | Sohn PD | Neuron | 2019 | PMID: 31542321 |
Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. | Spina S | Neurology | 2017 | PMID: 28130473 |
Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau. | Yanagi K | Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society | 2009 | PMID: 20377816 |
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. | Tanemura K | The Journal of neuroscience : the official journal of the Society for Neuroscience | 2002 | PMID: 11756496 |
Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. | Hutton M | Neurology | 2001 | PMID: 11402146 |
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. | Poorkaj P | Archives of neurology | 2001 | PMID: 11255441 |
Tau is a candidate gene for chromosome 17 frontotemporal dementia. | Poorkaj P | Annals of neurology | 1998 | PMID: 9629852 |
Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. | Alonso AC | Nature medicine | 1996 | PMID: 8673924 |
Text-mined citations for rs63750570 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.